dc.creatorMotta, Alicia Beatriz
dc.date.accessioned2020-12-10T16:42:07Z
dc.date.accessioned2022-10-14T21:37:42Z
dc.date.available2020-12-10T16:42:07Z
dc.date.available2022-10-14T21:37:42Z
dc.date.created2020-12-10T16:42:07Z
dc.date.issued2019-10
dc.identifierMotta, Alicia Beatriz; Epigenetic marks in Polycystic Ovary Syndrome; Bentham Science Publishers; Current Medicinal Chemistry; 26; 10-2019; 1-7
dc.identifier0929-8673
dc.identifierhttp://hdl.handle.net/11336/120111
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4309472
dc.description.abstractPolycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that affects women in their reproductive age. Recent studies have shown that genes have an important role in the etiology of PCOS. However, the precise way in which these genes are transcriptionally and post-transcriptionally regulated is poorly understood. The aim of the present review is to provide updated information on miRNAs and DNA methylation as epigenetic marks of PCOS. The data presented here allow concluding that both microRNAs and DNA methylation can be considered as possible useful biomarkers when choosing the treatment for a specific PCOS phenotype and thus represent two important tools for the diagnosis and treatment of PCOS patients.
dc.languageeng
dc.publisherBentham Science Publishers
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://pubmed.ncbi.nlm.nih.gov/31580245/
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.eurekaselect.com/175312/article
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPOLYCYSTIC OVARY SYNDROME
dc.subjectEPIGENETIC MARKS
dc.subjectDNA METHYLATION
dc.subjectmiRNAs
dc.subjectPCOS phenotypes
dc.titleEpigenetic marks in Polycystic Ovary Syndrome
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución